170857 ⎘
Detection or diagnosis of diseases; Psychoses; Psychiatry Mood disorders, e.g. bipolar, depression
METHODS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS
#2COMPOSITIONS, DEVICES, AND METHODS OF DEPRESSION SENSITIVITY TESTING
#3BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA
#4METHODS AND SYSTEMS FOR IDENTIFYING OR TREATING CENTRAL NERVOUS SYSTEMS DISEASE
#5COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING PSYCHIATRIC ILLNESS
#6ASSESSMENT METHODS AND DIAGNOSTIC KIT FOR PREDICTING SUICIDAL BEHAVIORS IN PATIENTS WITH DEPRESSIVE DISORDERS USING MULTIMODAL SERUM BIOMARKERS
#7METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING TRYPTOPHAN AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF
#8USE OF HYPOXIA-INDUCIBLE FACTOR 1 ALPHA AS MARKER IN DEPRESSION RECURRENCE DIAGNOSIS
#9USE OF ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES FOR THE TREATMENT AND DIAGNOSIS OF MOOD DISORDERS
#10NEUROTRANSMITTER TRANSPORT IN PROBIOTICS
#11METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING N-ACETYL-L-TRYPTOPHAN AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF
#12METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING CONJUGATED BILE ACIDS AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF
#13METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING TRIGONELLINE AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF
#14ANTI-HERV-W ENVELOPE PROTEIN ANTIBODY FOR USE IN THE TREATMENT OF PSYCHOTIC DISEASES
#15ASSESSMENT AND TREATMENT OF DEPRESSION, ANXIETY, OR RELATED DISORDERS
#16BILE ACID METABOLITES FOR DIAGNOSING AND TREATING DEPRESSIVE DISORDERS
#17TEST FOR MILD COGNITIVE IMPAIRMENT
#182-METHYLBUTYRATE, A BIOMARKER FOR IMPROVEMENTS OF MOOD DISORDERS
#19PHENOL, A BIOMARKER FOR IMPROVEMENTS OF THE MOOD DISORDERS
#20METHOD FOR PREDICTING A SUBJECT'S RESPONSE TO SLC MODULATOR THERAPY
#21BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA
#22METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES
#23LSD DOSE IDENTIFICATION
#24USE OF GDF11 TO DIAGNOSE AND TREAT ANXIETY AND DEPRESSION
#25ASSESSMENT METHODS AND DIAGNOSTIC KIT FOR PREDICTING SUICIDAL BEHAVIORS IN PATIENTS WITH DEPRESSIVE DISORDERS USING MULTIMODAL SERUM BIOMARKERS
#26USE OF SYNAPTOTAGMIN-7 IN THE DIAGNOSIS AND TREATMENT OF BIPOLAR DISORDER
#27BIOMARKER OF DRUG-INDUCED CELLULAR TOXICITY AND DEPRESSION
#28Biomarker for diagnosing depression and uses thereof
#29COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES
#30METHODS AND COMPOSITIONS FOR DIAGNOSING DEPRESSION
#31ASSESSMENT METHOD AND DIAGNOSTIC KIT FOR PREDICTING LONG-TERM PROGNOSIS OF ACUTE CORONARY SYNDROME ASSOCIATED WITH DEPRESSION
#32LSD dose identification
#33A METHOD FOR DIFFERENTIALLY DIAGNOSING IN VITRO A BIPOLAR DISORDER AND A MAJOR DEPRESSIVE DISORDER
#34METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS
#35Method for predicting a subjects response to SLC modulator therapy
#36Systems and methods to identify persons and/or identify and quantify pain, fatigue, mood, and intent with protection of privacy
#37Neurotransmitter transport in probiotics
#38Nanovesicles derived from bacteria of genus and use thereof
#39PREDICTING SUICIDALITY USING A COMBINED GENOMIC AND CLINICAL RISK ASSESSMENT
#40Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment and diagnosis of mood disorders
#41Biomarkers for bipolar disorder and schizophrenia
#42ANIMAL MODEL OF A MOOD DISORDER AND SCREENING METHOD
#43Application of PDCD4 as a therapeutic target for antidepressants and/or anxiolytics drugs
#44Diagnostics Platform for Mitochondrial Dysfunctions/Diseases
#45Vreceptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
#46COMBINATION THERAPIES FOR TREATING BIPOLAR DISORDER, AND METHODS FOR USING THE SAME
#47METHODS FOR IDENTIFYING MODULATORS OF MEMBRANE POTENTIALS IN BIPOLAR DISORDER AND ATTENTION DEFICIT HYPERACTIVITY DISORDER
#48Compositions, devices, and methods of depression sensitivity testing
#49METHOD FOR DETECTING BRAIN RELATED MALADIES USING OCULAR FLUID
#50ASSAY FOR THE DIAGNOSIS OF A NEUROLOGICAL DISEASE
#51Treatment for therapy refractory depression
#52Neurotransmitter transport in probiotics
#53Method for diagnosing, treating, or preventing mood disorders
#54BIOMARKER FOR DIAGNOSING DEPRESSION AND USE OF SAID BIOMARKER
#55Method for predicting a subject's response to valproic acid therapy
#56Peripheral measure of central brain inflammation, markers therefor and uses thereof
#57METHODS FOR DETECTION OF DEPRESSIVE DISORDERS
#58Method for decreasing depression-like behavior with connective tissue growth factor (CTGF) inhibitor
#59Predicting suicidality using a combined genomic and clinical risk assessment
#60Serum biomarker panels for bipolar disorder
#61BIOMARKER FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS
#62Biomarker for mental disease
#63Method and kit for diagnosing depression after acute coronary syndrome using homocysteine
#64Compositions and methods for identifying depressive disorders
#65V1B RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF PATIENTS HAVING AN ELEVATED AVP LEVEL AND/OR AN ELEVATED COPEPTIN LEVEL
#66Systems and methods to identify persons and/or identify and quantify pain, fatigue, mood, and intent with protection of privacy
#67Biomarkers predictive of predisposition to depression and response to treatment
#68BIOMARKERS FOR DISTINGUISHING MOOD DISORDERS
#69EVALUATION OF THE POTENTIAL RISK OF DRUG INDUCED MOOD DISTURBANCE AND SUICIDE: USE OF A DEDICATED PLATFORM
#70DISEASE SUSCEPTIBILITY
#71Markers for mood disorders
#72Quantifying biomarkers for diagnosing and treating schizophrenia, bipolar disorder or major depression
#73Factor involved in latent infection with herpes virus, and use thereof
#74METHOD FOR PREDICTING OPTION OF DEPRESSION TREATMENT DRUG
#75MULTIPLE BIOMARKER PANELS TO STRATIFY DISEASE SEVERITY AND MONITOR TREATMENT OF DEPRESSION
#76Methods for detection of depressive disorders
#77Methods for identifying modulators of membrane potentials in bipolar disorder and attention deficit hyperactivity disorder
#78HUMAN BIOMARKER TEST FOR MAJOR DEPRESSIVE DISORDER
#79Use of Sortilin as Biomarker for Affective/Mood Disorders
#80QUANTITAQUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS
#81Methods of diagnosing bipolar disorders and screening for therapeutic compounds
#82TRANSGENIC ANIMAL MODEL OF MOOD DISORDERS
#83Blood biomarkers for suicidality
#84Method for determining depression, kit for analyzing serotonin transporter, and kit for analyzing ubiquitinated serotonin transporter in blood
#85Biomarker for psychiatric and neurological disorders
#86Methods for detection of depressive disorders
#87Marker for response to antidepressant therapy
#88BLOOD BASED METHODS OF ASSESSING ADOLESCENT DEPRESSION IN A SUBJECT
#89Methods for treating ADHD and bipolar disorder using a membrane potential ratio test
#90Schizophrenia-associated genetic loci identified in genome wide association studies and methods of use thereof
#91QUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS
#92Diagnostic method for diagnosing depression and monitoring therapy effectiveness
#93Immunoassay of S-adenosylmethionine in personalized medicine and health or cancer evaluation
#94METHODS OF IDENTIFYING COMPOUNDS FOR TREATING DEPRESSION AND OTHER RELATED DISEASES
#95Methods for Diagnosing Mood Disorders
#96COVALENTLY BOUND METABOLITES AS BIOMARKERS
#97Susceptibility to and stratification for monoaminergic antidepressants
#98System and Method for Detecting and Diagnosing Schizophrenia and Depression
#99GAMMA-AMINOBUTYRIC ACID A RECEPTOR SUBUNIT BIOMARKERS
#100Biomarker of depression, method for measuring biomarker of depression, computer program, and recording medium
#101NOVEL THERAPEUTIC AND DIAGNOSTIC PRODUCTS AND METHODS
#102Two-photon absorbing compound with methods of synthesis and use
#103Raising and diagnosing of serotonin level
#104Methods for diagnosing and identifying modulators of membrane potentials in bipolar disorder and attention deficit hyperactivity disorder
#105Method for determining depression, kit for analyzing serotonin transporter, and kit for analyzing ubiquitinated serotonin transporter in blood
#106System and method for diagnosis and treatment
#107Administration of FGF9 for treatment of anxiety
#108Factor involved in latent infection with herpesvirus, and use thereof
#109ENZYMATIC DETERMINATION OF LITHIUM IONS USING PHOSPHOGLUCOMUTASE
#110Compositions and methods for modulating dopamine neurotransmission
#111Measurement of brain CDP-diacylglycerol synthase 1 enzyme and uses thereof
#112METHODS FOR DIAGNOSING MOOD DISORDERS
#113Quantitative diagnostic methods using multiple parameters
#114Biomarker for depression, method for measuring a biomarker for depression, computer program, and recording medium
#115Methods for treating depression using NCAM peptide mimetics
#116Disease susceptibility
#117System and method for diagnosis and treatment
#118Diagnosis of depression
#119BIOMARKERS FOR MONITORING TREATMENT OF NEUROPSYCHIATRIC DISEASES
#120Evaluation of the potential risk of drug induced mood disturbance and suicide: use of a dedicated platform
#121METHODS FOR DETECTION OF DEPRESSIVE DISORDERS
#122BIOMARKERS
#123BIOMARKERS
#124METHOD FOR PROVIDING INFORMATION ON ANTIDEPRESSANT THERAPEUTIC EFFECT USING SINGLE NUCLEOTIDE POLYMORPHISM
#125NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE THEREFOR
#126INFLAMMATORY BIOMARKERS FOR MONITORING DEPRESSIVE DISORDERS
#127DIAGNOSING AND MONITORING DEPRESSION DISORDERS BASED ON MULTIPLE SERUM BIOMARKER PANELS
#128Multiple Biomarker Panels to Stratify Disease Severity and Monitor Treatment of Depression
#129Methods and compositions for the treatment of symptoms of neurological and mental health disorders
#130Compositions and methods for modulating dopamine neurotransmission
#131Methods and compositions for treatment and prevention of major depressive disorder
#132METHOD FOR DIAGNOSING AND TREATING CHRONIC PSYCHIATRIC ILLNESSES AND MARKERS AND TARGETS FOR SUCH METHODS
#133COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING NEUROPSYCHIATRIC DISORDERS
#134Manipulation of brain CDP-diacylglycerol and uses thereof
#135Biomarkers for psychosis
#136SECRETOGRANIN AND VGF PEPTIDE BIOMARKERS AND USES THEREOF
#137Diagnosis of mood disorders by detecting latent infection with human herpesvirus-6
#138BLOOD BIOMARKERS FOR MOOD DISORDERS
#139METHODS TO IDENTIFY MODULATORS OF B-RAF PROTEIN KINASE AND THEIR USE FOR THE TREATMENT OF ANXIETY AND DEPRESSION
#140Biological Load Indicator and Method of Measuring Biological Load
#141Biomarkers for depression and methods using the same
#142Novel therapeutic and diagnostic products and methods
#143Metabolic syndrome and HPA axis biomarkers for major depressive disorder
#144Blood Based Methods for Assessing Adolescent Depression in a Subject
#145HUMAN BIOMARKER HYPERMAPPING FOR DEPRESSIVE DISORDERS
#146GENES AND PATHWAYS INVOLVED IN BIPOLAR DISORDER
#147Method of treating depression
#148Process of Screening a Molecule as a Candidate Drug for the Treatment of Bipolar Disorder
#149Method of diagnosing neuropsychiatric diseases, eating disorders or metabolic diseases
#150Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#151Stress evaluating apparatus, method, system and program and recording medium therefor
#152FGF2-RELATED METHODS FOR DIAGNOSING AND TREATING DEPRESSION
#153Method to Diagnose or Screen for Inflammatory Diseases
#154Method of ameliorating symptom caused by mood disturbance
#155Method for identifying antipsychotic drug candidates
#156NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE THEREFOR
#157PAR-4 RELATED METHODS AND COMPOSITIONS
#158Neuroactive steroid compositions and methods of use therefor
#159METHOD OF TREATING STRESS-MEDIATED DEPRESSION
#160Method for Improving Symptom of Mood Disorder
#161Methods and compositions for the diagnosis and treatment of schizophrenia
#162FGF2-RELATED METHODS FOR DIAGNOSING AND TREATING DEPRESSION
#163METHODS FOR DRUG DISCOVERY, DISEASE TREATMENT, AND DIAGNOSIS USING METABOLOMICS
#164Antibody for diagnosing neuropsychiatric diseases, in particular schizophrenia, depression and bipolar affective disorders
#165Diagnosis and treatment of mood disorders
#166Compositions and Methods For Modulating Dopamine Nerutransmission
#167MEANS AND METHODS FOR DIAGNOSING AND TREATING AFFECTIVE DISORDERS
#168Methods of dignosing or treating depression on basis of increased cerebrospinal fluid levels of neurotrodhin 3
#169Methods for diagnosing an attention-deficit/Hyperactivity disorder
#170Methods for diagnosing bipolar disorder
#171Methods for diagnosing major depression or schizophrenia
#172Methods for Diagnosing Schizophrenia
#173GENES ASSOCIATED WITH UNIPOLAR DEPRESSION
#174Means and methods for diagnosing and treating affective disorders
#175Methods of identifying agents for treatment of schizophrenia and related disorders
#176METHODS OF IDENTIFYING AGENTS FOR TREATING NEUROLOGICAL DISORDERS
#177Manipulation of brain CDP-diacylglycerol and uses thereof
#178Methods for diagnosis and prognosis of psychotic disorders
#179Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#180Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#181Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#182αβδGABA-A receptors as a strategy for PMS and alcoholism
#183Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#184Methods of determining compounds useful in the treatment of bipolar disorder and methods of treating such disorders
#185Computer systems and methods for inferring casuality from cellular constituent abundance data
#186METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS
#187Use of pp2a phosphatase modulators in the treatment of mental disorders
#188Compositions and methods for diagnosing and treating neuropsychiatric disorders
#189Computer systems and methods for inferring causality from cellullar constituent abundance data
#190Methods for drug discovery disease treatment, and diagnosis using metabolomics
#191Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#192Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#193Means and methods for diagnosing and treating affective disorders
#194Methods for diagnosis of major depressive disorder
#195KCNQ2-15 potassium channel
#196Administration of FGF2 for treamtent of anxiety
#197Promoter sequences for corticotropin releasing-factor receptor CRF2α and method of identifying agents that alter the activity of the promoter sequences
#198Mutations of the 5' region of the human 5-HT1A gene, associated proteins of the 5' region and a diagnostic test for major depression and related mental illnesses
#199Diagnostic markers of mood disorders and methods of use thereof
#200Means and methods for diagnosing and treating affective disorders
#201Methods for diagnosing a bipolar disorder and unipolar disorder
#202Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#203Molecular diagnostic kits for evaluating stress